Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Surgery
Published in: European Surgery 3/2018

Open Access 01-06-2018 | main topic

Optimal perioperative care in peri-hilar cholangiocarcinoma resection

Authors: Leonard M. Quinn, Declan F. J. Dunne, MD, Robert P. Jones, PhD, Graeme J. Poston, MS, Hassan Z. Malik, MD, Stephen W. Fenwick, MD

Published in: European Surgery | Issue 3/2018

Login to get access

Summary

Surgical resection remains the only proven curative treatment for peri-hilar cholangiocarcinoma. Despite recent advances in liver surgery techniques and perioperative care, resection for peri-hilar cholangiocarcinoma remains associated with significant morbidity and mortality. Considerable variation in the perioperative management of these patients exists. Optimal perioperative management has the potential to deliver improved outcomes. This article seeks to summarize the evidence underpinning best practice in the perioperative care of patients undergoing resection of peri-hilar cholangiocarcinoma. The authors also seek to identify areas where research efforts and future clinical trials should be targeted.
Literature
1.
Khan SA, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657–69.CrossRefPubMed
2.
3.
Gomez D, Patel PB, Lacasia-Purroy C, et al. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. Eur J Surg Oncol. 2014;40(1):77–84.CrossRefPubMed
4.
Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129–40.CrossRefPubMed
5.
DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755.CrossRefPubMedPubMedCentral
6.
Janargin WR, Fong Y, DeMatteo RP, et al. Staging, resectability and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507–17.CrossRef
7.
Edge SB, Byrd DR, Compton CC, et al., editors. American joint committee on cancer staging manual. 7th ed. New York: Springer; 2010.
8.
Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223(4):384.CrossRefPubMedPubMedCentral
9.
Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery. 1998;123(2):131.CrossRefPubMed
10.
Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230(5):663.CrossRefPubMedPubMedCentral
11.
Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer. 1997;79(1):26.CrossRefPubMed
12.
Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is liver transplantation appropriate for patients with potentially resectable de novo Hilar cholangiocarcinoma? J Am Coll Surg. 2015;221(1):130–9.CrossRefPubMed
13.
Rea DJ, Heimback JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242(3):451–8.PubMedPubMedCentral
14.
Laurent A, Tayar C, Cherqui D. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford). 2008;10(2):126.CrossRef
15.
Ribero D, Zimmitti G, Aloia TA, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223(1):87–97.CrossRefPubMedPubMedCentral
16.
Moole H, Bechtold M, Puli S. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol. 2016;14:182.CrossRefPubMedPubMedCentral
17.
Wiggers JK, Coelen RJ, Rauws EA. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial. BMC Gastroenterol. 2015;14(15):20. https://​doi.​org/​10.​1186/​s12876-015-0251-0.CrossRef
18.
Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12:103.CrossRefPubMedPubMedCentral
19.
Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204(5):854.CrossRefPubMed
20.
Kennedy TJ, Yopp Qin AY, et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11(5):445–51.CrossRef
21.
Kooby DA, Zakian KL, Challa ZN, et al. Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection. Cancer Res. 2000;60(14):3800–6.PubMed
22.
Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982–99.CrossRefPubMedPubMedCentral
23.
Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237(5):686.PubMedPubMedCentral
24.
Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243(3):364.CrossRefPubMedPubMedCentral
25.
Olthof PB, Coelen RJS, Wiggers JK, et al. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB (Oxford). 2017;19(5):381–7.CrossRef
26.
Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 2002;235(3):392.CrossRefPubMedPubMedCentral
27.
Bird N, Elmasry M, Jones R, et al. Role of staging laparoscopy in stratification of patients with perihilar cholangiocarcinoma. Br J Surg. 2017;104(4):418–25.CrossRefPubMed
28.
Coelen RJS, Ruys AT, Besselink MG, et al. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surg Endosc. 2016;30(10):4163–73.CrossRefPubMedPubMedCentral
29.
Coelen RJ, Ruys AT, Wiggers JK, et al. Development of a risk score to predict detection of metastasized or locally advanced perihilar cholangiocarcinoma at staging laparoscopy. Ann Surg Oncol. 2016;23(suppl 5):904–10.CrossRefPubMedPubMedCentral
30.
31.
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.CrossRefPubMed
32.
Parkin E, Plumb AA, O’Reilly D, Renehan AD. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(7):1021–2.CrossRefPubMed
33.
Otsuji H, Yokoyama Y, Ebata T, et al. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015;39(6):1494–500.CrossRefPubMed
34.
Okumura S, Kaido T, Hamaguchi Y, et al. Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of Intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2017;24(4):1037–45.CrossRefPubMed
35.
Kasivisvanathan R, Abbassi-Ghadi R, McLeod AD, et al. Cardiopulmonary exercise testing for predicting post-operative morbidity in patients undergoing hepatic resection surgery. HPB (Oxford). 2015;17(7):637–43.CrossRef
36.
Dunne DF, Jones RP, Lythgoe D, et al. Cardiopulmonary exercise testing before liver surgery. J Surg Oncol. 2014;110(4):439–44.CrossRefPubMed
37.
Wynter-Blyth V, Moorthy K. Prehabilitation: preparing patients for surgery. BMJ. 2017;358(8):j3702.CrossRefPubMed
38.
Moran J, Guinan E, McCormick P, et al. The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. Surgery. 2016;160(5):1189–201.CrossRefPubMed
39.
Dunne DF, Jack S, Jones RP, et al. Randomised clinical trial of prehabilitation before planned liver resection. Br J Surg. 2016;103(5):504–12.CrossRefPubMed
40.
41.
Coolsen MM, Wong-Lun-Hing EM, van Dam RM, et al. A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways. HPB (Oxford). 2013;15(4):245–51.CrossRef
42.
Hall TC, Dennison AR, Bilku DK, et al. Enhanced recovery programmes in hepatobiliary and pancreatic surgery: a systematic review. Ann R Coll Surg Engl. 2012;94(5):318–26.CrossRefPubMedPubMedCentral
43.
Jones C, Kelliher L, Dickinson M, et al. Randomised clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg. 2013;100(8):1015–24.CrossRefPubMed
44.
Savikko J, Ilmakunas M, Makisalo H, et al. Enhanced recovery protocol after liver resection. Br J Surg. 2015;103(5):617.
45.
Dunne DF, Yip VS, Jones RP, et al. Enhanced recovery in the resection of colorectal liver metastases. J Surg Oncol. 2014;110(2):197–202.CrossRefPubMed
46.
Ahmed EA, Montalti R, Niccolini D, et al. Fast track program in liver resection: A PRISMA compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95(28):e4154.CrossRef
47.
Zhao Y, Qin H, Wu Y, Xiang B. Enhanced recovery after surgery program reduces length of stay and complications in liver resection: A PRISMA compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(31):e7628.CrossRef
48.
Yip VS, Dunne DF, Samuels S, et al. Adherence to early mobilisation: Key for successful enhanced recovery after liver resection. Eur J Surg Oncol. 2016;42(10):1561–7.CrossRefPubMed
49.
Eckel F, Brunner T, Jelic S, ESMO Guidelines Working Group. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):vi40–vi4.PubMed
50.
Neoptolemos JP, Moore MJ, Cox TF et al. European Study Group for Pancreatic Cancer. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147.CrossRef
51.
Capecitabine Extends Survival for Biliary Tract Cancer. Cancer Discov. 2017 Jul;7(7):OF1.
52.
Primrose JN, Fox R, Palmer DH, et al. Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study (abstract). J Clin Oncol. 2017;35(15 suppl):abstr 4006.CrossRef
53.
McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg. 1997;174(6):605.CrossRefPubMed
54.
Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009;73(1):148.CrossRefPubMed
Metadata
Title
Optimal perioperative care in peri-hilar cholangiocarcinoma resection
Authors
Leonard M. Quinn
Declan F. J. Dunne, MD
Robert P. Jones, PhD
Graeme J. Poston, MS
Hassan Z. Malik, MD
Stephen W. Fenwick, MD
Publication date
01-06-2018
Publisher
Springer Vienna
Published in
European Surgery / Issue 3/2018
Print ISSN: 1682-8631
Electronic ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-018-0529-x

Other articles of this Issue 3/2018

European Surgery 3/2018 Go to the issue

editorial

Contemporary liver surgery

main topic

Liver resection for non-colorectal metastases

main topic

Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma

main topic

Perioperative management of liver surgery—review on pathophysiology of liver disease and liver failure

main topic

Technical advances and future perspectives in liver surgery

main topic

Shaping the future of liver surgery